S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33
S&P 500   4,455.48
DOW   34,798.00
QQQ   373.33

Intec Pharma Earnings Date, Estimates, & History

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range N/A
50-Day Range
52-Week Range N/A
Volume988,300 shs
Average Volume543,436 shs
Market Capitalization$8.65 million
P/E RatioN/A
Dividend YieldN/A

Intec Pharma Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Intec Pharma Estimated Revenue and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Intec Pharma (NASDAQ:NTEC) Earnings Estimates

Current Year EPS Consensus Estimate: $11.96 EPS
Next Year EPS Consensus Estimate: $-9.8 EPS

Intec Pharma (NASDAQ:NTEC) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueActions
3/13/2020Q4 2019($16.00)($8.00)+$8.00($0.02)
8/9/2019Q2 2019($22.40)($24.00)($1.60)($0.30)
2/27/2019Q4 2018($24.00)($30.40)($6.40)($0.38)
8/15/2018Q2 2018($25.60)($27.20)($1.60)($0.34)
3/9/2018Q4 2017($16.00)($31.20)($15.20)($0.39)
11/15/2017Q3 2017($27.20)($32.00)($4.80)($0.40)
8/9/2017Q2 2017($37.60)($37.60)($0.47)
4/7/2017Q4 2016($25.60)($25.60)($0.32)
9/1/2016Q2 2016($29.60)($14.40)+$15.20($0.18)
3/14/2016Q4 2015($8.00)($23.20)($15.20)($0.29)
11/5/2015Q3 2015($5.60)($12.80)($7.20)($0.16)
8/31/2015Q2 2015($12.80)($12.80)($0.16)
(Earnings results data provided by Zacks Investment Research)
speech bubbles
speech bubbles

Intec Pharma (NASDAQ:NTEC) Earnings Frequently Asked Questions

How much profit does Intec Pharma generate each year?

Intec Pharma (NASDAQ:NTEC) has a recorded net income of -$14.13 million. NTEC has generated -$16.32 earnings per share over the last four quarters.

What is Intec Pharma's EPS forecast for next year?

Intec Pharma's earnings are expected to decrease from $11.96 per share to ($9.80) per share in the next year.

This page was last updated on 9/25/2021 by MarketBeat.com Staff


Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.